Ozempic and GLP-1 Blindness Lawsuit Update, Were You Affected? In re: GLP-1 RAs NAION Products Liability Litigation, MDL No. 3163
[UPDATED September 24, 2026 — Case count updated to 216 pending cases (JPML, September 1, 2026). Regulator actions, U.S. label check, court schedule and timeline rewritten. Corrected: the October 2026 discovery date is a defense proposal, not a court deadline. Settlement status unchanged: none.] Novo Nordisk is a defendant in In re: GLP-1 RAs NAION…
